Cue Health Receives FDA Warning Letter Regarding Emergency Use Authorized COVID-19 Test

(RTTNews) - Cue Health Inc. (HLTH) said it has received a warning letter from the U.S. Food and Drug Administration or FDA about its Emergency Use Authorized (EUA) COVID-19 test. The company is currently evaluating the letter and determining its response, with more information to follow in the next few days.

HLTH closed Monday's regular trading at $0.1222 down $0.0067 or 5.20%. But in the after-hours trading the stock gained $0.01 or 6.30%.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.